Via The Victory Formation: Why no love for Moses Malone or Dr. J? A Philadelphia drug-dealer was busted over the weekend for allegedly selling 140 bags of dope, the Philadelphia Daily News reports. The name imprinted on the bag? Miami Heat superstar forward, LeBron James. It is unknown just how popular LeBron James brownstone was selling in the Philly area, but police say Marlon Guess, 19, attempted to sell about $105K worth of it in one shot. I have to say, not a very bright move on his part. As a result, his bail to be sprung is set at $250K. Upper Darby Police Superintendent, Michael Chitwood, had the great Captain Obvious line following the arrest: I dont think LeBron James would be too happy with this drug-dealer dude using his name on these street bags. Gee, ya think? For what it is worth, this is commonplace within the drug-selling business. Often times, drugs will be nicknamed after celebrities or places, as a way to market the drug without getting detection from authorities. Of course, this usually comes to an end when you actually attempt to sell to the authorities like this genius. H/T Philly.com More The Victory Formation Go … Continue reading →

ALBANY, New York, October 2, 2012 /PRNewswire/ -- According to a new market report published by Transparency Market Research (http://www.transparencymarketresearch.com) "Infertility Drugs andDevices Market - Global IndustryAnalysis, Size, Share and Forecast,2010 - 2017", the overall infertility drugs and devices market was estimated at USD 3,553.5 million in 2010 and is expected to reach an estimated value of USD 4,776.4 million by 2017, growing at a CAGR of 4.3% from 2012 - 2017. The global infertility drugs market revenue for the year 2010 was estimated at USD 2,486.7 million and is expected to reach an estimated value of USD 3,352.7 million in 2017, growing at a CAGR of 4.3% from 2012 - 2017. The global infertility devices market revenue was estimated at USD 1,066.7 million in 2010 and is expected to reach an estimated value of USD 1,423.6 million by 2017, growing at a CAGR of 4.2% from 2012 - 2017. Browse thefull reportathttp://www.transparencymarketresearch.com/infertility-drugs-devices-market.html The key growth drivers for infertility drugs and devices market include rising number of infertile people, increasing worldwide obesity and rising disposable incomes of the consumers. Other driving factors include rising number of smokers, increasing stress and pollution, adoption of babies by homosexual couples and the availability … Continue reading →

Last week I focused on drug advertisement for Low T catching up with all the attention given to menopausal women with declining hormones. But women still are the primary targets for pharmaceutical advertising, in part because they can be captured for multiple productsif not quite from the cradle, at least from puberty, through pregnancy, to menopause and to grave. What are some of the consequences of this relentless focus on womens hormones and common symptoms? For one, it seems to promote a nation of hypochondriacs. It is extremely profitable for pharmaceutical companies, but it is not so good for the target of this attention, women. For example, for the younger set, we have a new illness, Premenstrual Dysphoric Disorder (PMDD). In my day, it was moodiness at that time of the month, more typically known as bitchiness. We didnt have an ICD-9 or DSM code. We had uncomfortable days but knew that this, too, would pass. Now cyclical hormones are a disease. The Diagnostic and Statistical Manual of Mental Disorders, revision four, made the diagnosis official, although an example of a depressive disorder not otherwise specified. It is said to affect 3-8% of reproductive age women. Not everyone agrees that … Continue reading →

NEW YORK (Reuters Health) - The cheap and popular heart drugs known as beta-blockers may be overused in many patients, exposing them needlessly to bothersome side effects, a new study suggests. Researchers found that people with stable heart disease who took beta-blockers were no less likely to die from their condition, or to suffer a heart attack or stroke, than were those not on the medications. Although the study is not conclusive, it "is definitely going to make some waves," said Dr. Lydia Bazzano of Tulane University in New Orleans, who studies heart disease prevention, but wasn't part of the new work. "I think there are probably plenty of people out there who are getting (beta-blockers), but don't need them," Bazzano told Reuters Health. Beta-blockers such as atenolol and metoprolol slow the heartbeat and lower blood pressure. They are known to shield against future heart attacks in people who just had one and can be helpful in certain types of heart failure. Older studies have suggested staying on beta-blockers in the long run may be beneficial, so many doctors have their patients take the drugs indefinitely. But those results predate modern treatment, researchers say. And whether or not beta-blockers can … Continue reading →